1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario registrado en Universia


Opción 1: Descargar recurso

Detalles del recurso

Descripción

Aggressive B-cell lymphoma (BCL) comprises a heterogeneous group of malignancies, including diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma, and mantle cell lymphoma (MCL). DLBCL, with its 3 subtypes, is the most common type of lymphoma. Advances in chemoimmunotherapy have substantially improved disease control. However, depending on the subtype, patients with DLBCL still exhibit substantially different survival rates. In MCL, a mature B-cell lymphoma, the addition of rituximab to conventional chemotherapy regimens has increased response rates, but not survival. Burkitt lymphoma, the most aggressive BCL, is characterized by a high proliferative index and requires more intensive chemotherapy regimens than DLBCL. Hence, there is a need for more effective therapies for all three diseases. Increased understanding of the molecular features of aggressive BCL has led to the development of a range of novel therapies, many of which target the tumor in a tailored manner and are summarized in this paper.

Pertenece a

PubMed Central (PMC3 - NLM DTD)  

Autor(es)

Foon, Kenneth A. -  Takeshita, Kenichi -  Zinzani, Pier L. - 

Id.: 55223208

Idioma: inglés  - 

Versión: 1.0

Estado: Final

Palabras claveReview Article - 

Tipo de recurso: Text  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

Requerimientos técnicos:  Browser: Any - 

Fecha de contribución: 27-abr-2012

Contacto:

Localización:

Otros recursos del mismo autor(es)

  1. A Phase 2 Study of Belinostat (PXD101) in Patients with Relapsed or Refractory Acute Myloid Leukemia or Patients Over 60 with Newly-Diagnosed Acute Myloid Leukemia: A California Cancer Consortium Study We performed a phase II study of belinostat in patients with acute myloid leukemia (AML). In this op...
  2. The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cells Chronic lymphocytic leukemia (CLL) is a common malignancy characterized by the accumulation of B lym...
  3. A phase I trial of recombinant gamma interferon in patients with cancer A total of 11 patients were treated on an escalating, single dose trial of recombinant gamma interfe...
  4. Biological therapy of cancer Interferons and monoclonal antibodies are among the most promising biological approaches to cancer t...
  5. Immunologic classification of lymphoma and lymphoid leukemia Important insights into lymphocyte differentiation and the cellular origins of lymphoma and lymphoid...

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.